Molecular Biology of the Enzymes that Degrade Endocannabinoids

Author(s): Robyn A. Puffenbarger

Journal Name: Current Drug Targets - CNS & Neurological Disorders
Continued as CNS & Neurological Disorders - Drug Targets

Volume 4 , Issue 6 , 2005


Endocannabinoid circuits have been shown to regulate a number of important pathways including pain, feeding, memory and motor coordination. Direct manipulation of endocannabinoid tone, therefore, may relieve disease symptoms related to analgesia, obesity, Alzheimers and Parkinsons in humans. The endocannabinoid circuit involves two cloned receptors: CB1 in the CNS and CB2 in the periphery; endogenously produced ligands including anandamide, 2-arachidonylglycerol and palmitoylethanolamide; and enzymes that degrade endocannabinoid ligands to terminate signaling. Currently, three enzymes have been characterized with the ability to hydrolyze endocannabinoids: fatty acid amide hydrolase (FAAH), monoglyceride lipase (MGL) and N-acylethanolamine-hydrolyzing acid amidase (NAAA). The purpose of this review is to examine the molecular biology for the enzymes that hydrolyze endocannabinoids covering the protein activity and expression, mRNA characterization, genomic locus organization, promoter analysis and knockout phenotypes.

Keywords: Endocannabinoid, cannabinoid receptor, fatty acid amide hydrolase, monoglyceride lipase, N-acylethanolaminehydrolyzing acid amidase, central nervous system, knockout mouse, review

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [625 - 631]
Pages: 7
DOI: 10.2174/156800705774933050
Price: $65

Article Metrics

PDF: 6